Traders sold shares of St. Jude Medical Inc. (NYSE:STJ) on strength during trading on Tuesday. $105.61 million flowed into the stock on the tick-up and $144.60 million flowed out of the stock on the tick-down, for a money net flow of $38.99 million out of the stock. Of all stocks tracked, St. Jude Medical had the 0th highest net out-flow for the day. St. Jude Medical traded up $0.38 for the day and closed at $78.63

A number of equities analysts have recently commented on STJ shares. Credit Suisse Group AG lowered St. Jude Medical from an “outperform” rating to a “neutral” rating and lifted their price objective for the stock from $67.00 to $81.00 in a research note on Tuesday, May 3rd. SunTrust Banks Inc. lowered St. Jude Medical from a “buy” rating to a “neutral” rating and boosted their price target for the company from $70.00 to $80.00 in a research note on Tuesday, May 10th. Barclays PLC lowered St. Jude Medical from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $74.00 to $80.00 in a research note on Wednesday, May 11th. Zacks Investment Research lowered St. Jude Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, June 14th. Finally, Leerink Swann lowered St. Jude Medical from an “outperform” rating to a “market perform” rating in a research note on Monday, July 11th. Twenty-two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $75.17.

The firm has a market capitalization of $22.40 billion and a P/E ratio of 34.19. The company’s 50 day moving average is $82.01 and its 200 day moving average is $70.57.

St. Jude Medical (NYSE:STJ) last announced its earnings results on Wednesday, July 20th. The medical technology company reported $1.06 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.06. During the same period in the prior year, the business posted $1.07 earnings per share. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.55 billion. The firm’s revenue for the quarter was up 10.8% compared to the same quarter last year. On average, equities analysts forecast that St. Jude Medical Inc. will post $4.06 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a dividend of $0.31 per share. The ex-dividend date is Wednesday, September 28th. This represents a $1.24 annualized dividend and a dividend yield of 1.58%.

A hedge fund recently raised its stake in St. Jude Medical stock. Dimensional Fund Advisors LP boosted its position in shares of St. Jude Medical Inc. (NYSE:STJ) by 32.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 823,890 shares of the medical technology company’s stock after buying an additional 199,858 shares during the period. Dimensional Fund Advisors LP owned 0.29% of St. Jude Medical worth $50,894,000 as of its most recent SEC filing.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.